TRIER PHARM ApS: Financial statements 2024
CVR: 31611083
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 8,646 and a net result of DKK -18,582 compared with DKK -116,420 the year before. Equity in the 2024 report amounted to DKK -565,626. The company had 1 employee in the financial year.
- Gross Profit
- DKK 8,646
- Profit/Loss
- DKK -18,582
- Equity
- DKK -565,626
- Total Assets
- DKK 170,027
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 9 t. | -19 t. | -566 t. | 1 |
| 2023 | - | -86 t. | -116 t. | -547 t. | - |
| 2022 | - | 61 t. | 36 t. | -431 t. | - |
| 2021 | - | 32 t. | 9 t. | -467 t. | - |
| 2020 | - | -35 t. | -56 t. | -476 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
TRIER PHARM ApS has published its annual report for 2023. Gross profit came to DKK -86,365, and the net result was DKK -116,420.
As of June 24, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of TRIER PHARM ApS.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.